The influence of human immunodeficiency virus-1 on hematopoiesis

Blood

Volumn 91, Issue 5, 1998, Pages 1479-1495

  Moses, Ashlee ^b   Nelson, Jay ^b   Bagby Jr , Grover C ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BLEOMYCIN; CYTOKINE; DACARBAZINE; DOXORUBICIN; GRANULOCYTE COLONY STIMULATING FACTOR; INTERLEUKIN 10; INTERLEUKIN 6; INTERLEUKIN 9; VINBLASTINE SULFATE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; BONE MARROW DEPRESSION; CANCER COMBINATION CHEMOTHERAPY; CLINICAL ARTICLE; HEMATOPOIESIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NEUTROPENIA; NONHODGKIN LYMPHOMA; NONHUMAN; PRIORITY JOURNAL; REVIEW; THROMBOCYTOPENIA;

EID: 0032030701     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v91.5.1479     Document Type: Review

References (189)

1. Mir N, Costello C, Luckit J, Lindley R: HIV-disease and bone marrow changes: A study of 60 cases. Eur J Haematol 42:339, 1989
2. Costello C: Haematological abnormalities in human immunodeficiency virus (HIV) disease. J Clin Pathol 41:711, 1988
3. Sun NCJ, Shapshak P, Lachant NA, Hsu M, Sieger L, Schmid P, Beall G, Imagawa DT: Bone marrow examination in patients with AIDS and AIDS-related complex (ARC). Am J Clin Pathol 92:589, 1989
4. van Elsacker-Niele AMW: Prevalence of parvovirus B19 infection in patients infected with human immunodeficiency virus. Clin Infect Dis 1997
5. Wickramasinghe SN, Shiels S: Bone marrow stromal cell damage in HIV infection. Clin Lab Haematol 15:236, 1993
6. Re MC, Zauli G, Furlini G, Ranieri S, Monari P, Ramazzotti E, La Placa M: The impaired number of circulating granulocyte/macrophage progenitors (CFU-GM) in human immunodeficiency virus-type 1 infected subjects correlates with an active HIV-1 replication. Arch Virol 129:53, 1993
7. Hillyer CD, Lackey DA, Villinger F, Winton EF, McClure HM, Ansari AA: CD34+ and CFU-GM progenitors are significantly decreased in SIVsmm9 infected rhesus macaques with minimal evidence of direct viral infection by polymerase chain reaction. Am J Hematol 43:274, 1993
8. Steinberg HN, Anderson J, Crumpacker CS, Chatis PA: HIV infection of the BS-1 human stroma cell line: Effect on murine hematopoiesis. Virology 193:524, 1993
9. Dietrich M, Baumgarte S, Hutert F, von Laer MD: HIV-1 infection of long term bone marrow cultures. Int Conf AIDS 8:B215, 1992
10. LaRussa VF, Mosca JD, Kaushal S, Cutting MA, Kessler SW, Reid T: CD34+ stromal cell precursors are possible targets for HIV. Blood 82:414a, 1993 (abstr, suppl 1)
11. Lunardi-Iskandar Y, Georgoulias V, Bertoli AM, Augery-Bourget Y, Ammar A, Vittecoq D, Rosenbaum W, Meyer P, Jasmin C: Impaired in-vitro proliferation of hemopoietic precursors in HIV-1-infected subjects. Leuk Res 13:573, 1989
12. Dournon E, Matheron S, Rozenbaum W, Gharakhanian S, Michon C, Girard PM, Perronne C, Salmon D, De Truchis P, Leport C: Effects of zidovudine in 365 consecutive patients with AIDS or AIDS-related complex. Lancet 2:1297, 1988
13. Levine AM, Wernz JC, Kaplan L, Rodman N, Cohen P, Metroka C, Bennett JM, Rarick MU, Walsh C, Kahn J: Low-dose chemotherapy with central nervous system prophylaxis and zidovudine maintenance in AIDS-related lymphoma. A prospective multi-institutional trial [see comments]. JAMA 266:84, 1991
14. Miles SA, Mitsuyasu RT, Moreno J, Baldwin G, Alton NK, Souza L, Glaspy JA: Combined therapy with recombinant granulocyte colony-stimulating factor and erythropoietin decreases hematologic toxicity from zidovudine. Blood 77:2109, 1991
15. Scadden DT, Bering HA, Levine JD, Bresnahan J, Evans L, Epstein C, Groopman JE: Granulocyte-macrophage colony-stimulating factor mitigates the neutropenia of combined interferon alpha and zidovudine treatment of acquired immune deficiency syndrome-associated Kaposi's sarcoma. J Clin Oncol 9:802, 1991
16. Pluda JM, Yarchoan R, Smith PD, McAtee N, Shay LE, Oette D, Maha M, Wahl SM, Myers CE, Broder S: Subcutaneous recombinant granulocyte-macrophage colony-stimulating factor used as a single agent and in an alternating regimen with azidothymidine in leukopenic patients with severe human immunodeficiency virus infection. Blood 76:463, 1990
17. Levine AM, Cheung T, Tulpule A, Huang J, Testa M: Preliminary results of AIDS clinical trials group (ACTG) study #149: Phase II trial of ABVD chemotherapy with G-CSF in HIV infected patients with Hodgkin's disease (HD). J Acquir Immune Defic Syndr Hum Retrovirol 14:A12, 1997 (abstr)
18. Bagby GC: Hematopoiesis, in Stamatoyannopoulos G (ed): The Molecular Basis of Hematology. Philadelphia, PA, Saunders, 1993, p 71
19. Moses AV, Williams S, Heneveld ML, Strussenberg J, Rarick M, Loveless M, Bagby G, Nelson JA: Human immunodeficiency virus infection of bone marrow endothelium reduces induction of stromal hematopoietic growth factors. Blood 87:919, 1996
20. Freedman AR, Zhu H, Levine JD, Kalams S, Scadden DT: Generation of human T lymphocytes from bone marrow CD34+ cells in vitro. Nat Med 2:46, 1996
21. Chelucci C, Hassan HJ, Locardi C, Bulgarini D, Pelosi E, Mariani G, Testa U, Federico M, Valtieri M, Peschle C: In vitro human immunodeficiency virus-1 infection of purified hematopoietic progenitors in single-cell culture. Blood 85:1181, 1995
22. Schwartz GN, Kessler SW, Rothwell SW, Burrell LM, Reid TJ, Meltzer MS, Wright DG: Inhibitory effects of HIV-1-infected stromal cell layers on the production of myeloid progenitor cells in human long-term bone marrow cultures [published erratum appears in Exp Hematol 23:181, 1995]. Exp Hematol 22:1288, 1994
23. Re MC, Zauli G, Gibellini D, Furlini G, Ramazzotti E, Monari P, Ranieri S, Capitani S, La Placa M: Uninfected haematopoietic progenitor (CD34+) cells purified from the bone marrow of AIDS patients are committed to apoptotic cell death in culture. AIDS 7:1049, 1993
24. + progenitor cells from asymptomatic patients are not a major reservoir for human immunodeficiency virus-1. Blood 86:1749, 1995
25. Zauli G, Re MC, Visani G, Furlini G, Mazza P, Vignoli M, La Placa M: Evidence for a human immunodeficiency virus type 1-mediated suppression of uninfected hematopoietic (CD34+) cells in AIDS patients. J Infect Dis 166:710, 1992
26. Zauli G, Re MC, Furlini G, Giovannini M, La Placa M: Human immunodeficiency virus type 1 envelope glycoprotein gp120-mediated killing of human haematopoietic progenitors (CD34+ cells). J Gen Virol 73:417, 1992
27. Molina JM, Scadden DT, Sakaguchi M, Fuller B, Woon A, Groopman JE: Lack of evidence for infection of or effect on growth of hematopoietic progenitor cells after in vivo or in vitro exposure to human immunodeficiency virus. Blood 76:2476, 1990
28. Davis BR, Schwartz DH, Marx JC, Johnson CE, Berry JM, Lyding J, Merigan TC, Zander A: Absent or rare human immunodeficiency virus infection of bone marrow stem/progenitor cells in vivo. J Virol 65:1985, 1991
29. De Luca A, Teofili L, Antinori A, lovino MS, Mencarini P, Visconti E, Tamburrini E, Leone G, Ortona L: Haemopoietic CD34+ progenitor cells are not infected by HIV-1 in vivo but show impaired clonogenesis. Br J Haematol 85:20, 1993
30. Bagnara GP, Zauli G, Giovannini M, Re MC, Furlini G, La Placa M: Early loss of circulating hemopoietic progenitors in HIV-1-infected subjects. Exp Hematol 18:426, 1990
31. + progenitor cells by granulocyte colony-stimulating factor in human immunodeficiency virus type 1-infected adults. Blood 88:3329, 1996
32. Miles SA, Mitsuyasu RT, Lee K, Moreno J, Alton K, Egrie JC, Souza L, Glaspy JA: Recombinant human granulocyte colony-stimulating factor increases circulating burst forming unit-erythron and red blood cell production in patients with severe human immunodeficiency virus infection. Blood 75:2137, 1990
33. Zauli G, Vitale M, Re MC, Furlini G, Zamai L, Falcieri E, Gibellini D, Visani G, Davis BR, Capitani S: In vitro exposure to human immunodeficiency virus type 1 induces apoptotic cell death of the factor-dependent TF-1 hematopoietic cell line. Blood 83:167, 1994
34. Oyaizu N, Chirmule N, Ohnishi Y, Kalyanaraman VS, Pahwa S: Human immunodeficiency virus type i envelope glycoproteins gp120 and gp160 induce interleukin-6 production in CD4+ T-cell clones. J Virol 65:6277, 1991
35. Shearer GM, Roilides E, Pizzo PA, Clerici M: CD4+ T helper cell function is actively suppressed in HIV infection. Int Conf AIDS 7:61, 1991
36. Luria S, Chambers I, Berg P: Expression of the type 1 human immunodeficiency virus Nef protein in T cells prevents antigen receptor-mediated induction of interleukin 2 mRNA. Proc Natl Acad Sci USA 88:5326, 1991
37. Smith BL, Krushelnycky BW, Mochly-Rosen D, Berg P: The HIV Nef protein associates with protein kinase C theta. J Biol Chem 271:16753, 1996
38. Baier G, Baier-Bitterlich G, Meller N, Coggeshall KM, Giampa L, Telford D, Isakov N, Altman A: Expression and biochemical characterization of human protein kinase C-theta. Eur J Biochem 225:195, 1994
39. Monks CRF, Kupfer H, Tamir E, Barlow A, Kupfer A: Selective modulation of protein kinase C-q during T-cell activation. Nature 385:83, 1997
40. Stella CC, Ganser A, Hoelzer D: Defective in vitro growth of the hemopoietic progenitor cells in the acquired immunodeficiency syndrome. J Clin Invest 80:286, 1987
41. Molina JM, Scadden DT, Amirault C, Woon A, Vannier E, Dinarello CA, Groopman JE: Human immunodeficiency virus does not induce interleukin-1, interleukin-6, or tumor necrosis factor in mononuclear cells. J Virol 64:2901, 1990
42. Chehimi J, Starr SE, Frank I, D'Andrea A, Ma X, MacGregor RR, Sennelier J, Trinchieri G: Impaired interleukin 12 production in human immunodeficiency virus-infected patients. J Exp Med 179:1361, 1994
43. Sperber K, Hamrang G, Louie MJ, Kalb T, Banerjee R, Choi HS, Paronetto F, Mayer L: Progressive impairment of monocytic function in HIV-1-infected human macrophage hybridomas. AIDS Res Hum Retroviruses 9:657, 1993
44. Bagby GC: Interleukin 1 and hematopoiesis. Blood Rev 3:152, 1989
45. Tripp CS, Wolf SF, Unanue ER: Interleukin 12 and tumor necrosis factor alpha are costimulators of interferon gamma production by natural killer cells in severe combined immunodeficiency mice with listeriosis, and interleukin 10 is a physiologic antagonist. Proc Natl Acad Sci USA 90:3725, 1993
46. Wu C-Y, Demeure C, Kiniwa M, Gately M, Delespesse G: IL-12 induces the production of IFN-gamma by neonatal human CD4 T cells. J Immunol 151:1938, 1993
47. Esser R, Glienke W, Von Briesen H, Rubsamen-Waigmann H, Andreesen R: Differential regulation of proinflammatory and hematopoietic cytokines in human macrophages after infection with human immunodeficiency virus. Blood 88:3474, 1996
48. Wiley CA, Schrier RD, Nelson JA, Lampen PW, Oldstone MB: Cellular localization of human immunodeficiency virus infection within the brains of acquired immune deficiency syndrome patients. Proc Natl Acad Sci USA 83:7089, 1986
49. Moses AV, Bloom FE, Pauza CD, Nelson JA: HIV infection of human brain capillary endothelial cells occurs via a CD4/GAL C-independent mechanism. Proc Natl Acad Sci USA 90:10474, 1993
50. Steffan AM, Lafon ME, Gendrault JL, Schweitzer C, Royer C, Jaeck D, Arnaud JP, Schmitt MP, Aubertin AM, Kirn A: Primary cultures of endothelial cells from the human liver sinusoid are permissive for human immunodeficiency virus type 1. Proc Natl Acad Sci USA 89:1582, 1992
51. Green DF, Resnick L, Bourgoignie JJ: HIV infects glomerular endothelial and mesangial but not epithelial cells in vitro. Kidney Int 41:956, 1992
52. Bahner I, Kearns K, Coutinho S, Leonard EH, Kohn DB: Infection of human marrow stroma by human immunodeficiency virus-1 (HIV-1) is both required and sufficient for HIV-1-induced hematopoietic suppression in vitro: Demonstration by gene modification of primary human stroma. Blood 90:1787, 1997
53. +) subset. J Clin Invest 68:1597, 1981
54. Bagby GC, Lawrence JH, Neerhout RC: Autoimmune granulopoietic failure: Identification of T-lymphocyte-mediated inhibition of granulopoiesis and prednisone responsiveness using in vitro techniques. N Engl J Med 309:1073, 1983
55. Geissler RG, Rossol R, Mentzel U, Ottmann OG, Klein AS, Gute P, Helm EB, Hoelzer D, Ganser A: Gamma delta-T cell-receptor-positive lymphocytes inhibit human hematopoietic progenitor cell growth in HIV type 1-infected patients. AIDS Res Hum Retroviruses 12:577, 1996
56. Badley AD, McElhinny JA, Leibson PJ, Lynch DH, Alderson MR, Paya CV: Upregulation of Fas ligand expression by human immunodeficiency virus in human macrophages mediates apoptosis of uninfected T lymphocytes. J Virol 70:199, 1996
57. Nagafuji K, Shibuya T, Harada M, Mizuno S, Takenaka K, Miyamoto T, Okamura T, Gondo H, Niho Y: Functional expression of Fas antigen (CD95) on hematopoietic progenitor cells. Blood 86:883, 1995
58. + human marrow cells is induced by interferon gamma and tumor necrosis factor alpha and potentiates cytokine-mediated hematopoietic suppression in vitro. Blood 85:3183, 1995
59. + cells of patients with aplastic anaemia. Br J Haematol 91:245, 1995
60. Rathbun RK, Faulkner GR, Ostroski MH, Christianson TA, Hughes G, Jones G, Cahn R, Maziarz RT, Royle G, Keeble W, Heinrich MC, Grompe M, Tower PA, Bagby GC: Inactivation of the Fanconi anemia group C (FAC) gene augments interferon-gamma-induced apoptotic responses in hematopoietic cells. Blood 90:974, 1997
61. Marandin A, Canque B, Coulombel L, Gluckman JC, Vainchenker W, Louache F: In vitro infection of bone marrow-adherent cells by human immunodeficiency virus type 1 (HIV-1) does not alter their ability to support hematopoiesis. Virology 213:245, 1995
62. Wang Z, Goldberg MA, Scadden DT: HIV-1 suppresses erythropoietin production in vitro. Exp Hematol 21:683, 1993
63. Ziegler JL, Drew WL, Miner RC, Mintz L, Rosenbaum E, Gershow J, Lennette ET, Greenspan J, Shillitoe E, Beckstead J, Casavant C, Yamamoto K: Outbreak of Burkitt's-like lymphoma in homosexual men. Lancet 2:631, 1982
64. Beral V, Peterman T, Berkelman R, Jaffe H: AIDS-associated non-Hodgkin lymphoma [see comments]. Lancet 337:805, 1991
65. Karp JE, Broder S: Acquired immunodeficiency syndrome and non-Hodgkin's lymphomas. Cancer Res 51:4743, 1991
66. Levine AM: AIDS-related malignancies: The emerging epidemic. J Natl Cancer Inst 85:1382, 1993
67. Astrin SM, Schattner E, Laurence J, Lebman RI, Rodriguez-Alfageme C: Does HIV infection of B lymphocytes initiate AIDS lymphoma? Detection by PCR of viral sequences in lymphoma tissue. Curr Top Microbiol Immunol 182:399, 1992
68. Prevot S, Raphael M, Fournier JG, Diebold J: Detection by in situ hybridization of HIV and c-myc RNA in tumour cells of AIDS-related B-cell lymphomas. Histopathology 22:151, 1993
69. Subar M, Neri A, Inghirami G, Knowles DM, Dalla-Favera R: Frequent c-myc oncogene activation and infrequent presence of Epstein-Barr virus genome in AIDS-associated lymphoma. Blood 72:667, 1988
70. Hamilton-Dutoit SJ, Pallesen G, Franzmann MB, Karkov J, Black F, Skinhoj P, Pedersen C: AIDS-related lymphoma. Histopathology, immunophenotype, and association with Epstein-Barr virus as demonstrated by in situ nucleic acid hybridization. Am J Pathol 138:149, 1991
71. Groopman JE, Sullivan JL, Mulder C, Ginsburg D, Orkin SH, O'Hara CJ, Falchuk K, Wong-Staal F, Gallo RC: Pathogenesis of B cell lymphoma in a patient with AIDS. Blood 67:612, 1986
72. Pelicci PG, Knowles DM 2d, Arlin ZA, Wieczorek R, Luciw P, Dina D, Basilico C, Dalla-Favera R: Multiple monoclonal B cell expansions and c-myc oncogene rearrangements in acquired immune deficiency syndrome-related lymphoproliferative disorders. Implications for lymphomagenesis. J Exp Med 164:2049, 1986
73. Kinlen L: Immunosuppressive therapy and acquired immunological disorders. Cancer Res 52:5474s, 1992 (suppl 19)
74. Biggar RJ, Rosenberg PS, Cote T, Goedert JJ: Non Hodgkin's lymphoma in AIDS: findings from linking AIDS and cancer registries. J Acquir Immune Defic Syndr Hum Retrovirol 14:A43, 1997 (abstr)
75. Levine AM, Shibata D, Sullivan-Halley J, Nathwani B, Brynes R, Slovak ML, Mahterian S, Riley CL, Weiss L, Levine PH: Epidemiological and biological study of acquired immunodeficiency syndrome-related lymphoma in the County of Los Angeles: Preliminary results. Cancer Res 52:5482s, 1992
76. Delecluse HJ, Raphael M, Magaud JP, Felman P, Alsamad IA, Bornkamm GW, Lenoir GM: Variable morphology of human immunodeficiency virus-associated lymphomas with c-myc rearrangements. The French Study Group of Pathology for Human Immunodeficiency Virus-Associated Tumors, I. Blood 82:552, 1993
77. Chadbum A, Cesarman E, Jagirdar J, Subar M, Mir RN, Knowles DM: CD30 (Ki-1) positive anaplastic large cell lymphomas in individuals infected with the human immunodeficiency virus. Cancer 72:3078, 1993
78. Carbone A, Gloghini A, Vaccher E, Zagonel V, Pastore C, Dalla Palma P, Branz F, Saglio G, Volpe R, Tirelli U, Gaidano G: Kaposi's sarcoma-associated herpesvirus DNA sequences in AIDS-related and AIDS-unrelated lymphomatous effusions. Br J Haematol 94:533, 1996
79. Cesarman E, Chang Y, Moore PS, Said JW, Knowles DM: Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas [see comments]. N Engl J Med 332:1186, 1995
80. Delecluse HJ, Anagnostopoulos I, Dallenbach F, Hummel M, Marafioti T, Schneider U, Huhn D, Schmidt-Westhausen A, Reichart PA, Gross U, Stein H: Plasmablastic lymphomas of the oral cavity: A new entity associated with the human immunodeficiency virus infection. Blood 89:1413, 1997
81. Carbone A, Gloghini A, Canzonieri V, Tirelli U: AIDS-related extranodal non-Hodgkin's lymphomas with plasma cell differentiation. Blood 90:1337, 1997
82. Raphael M, Gentilhomme O, Tulliez M, Byron PA, Diebold J: Histopathologic features of high-grade non-Hodgkin's lymphomas in acquired immunodeficiency syndrome. The French Study Group of Pathology for Human Immunodeficiency Virus-Associated Tumors. Arch Pathol Lab Med 115:15, 1991
83. Lowenthal DA, Straus DJ, Campbell SW, Gold JW, Clarkson BD, Koziner B: AIDS-related lymphoid neoplasia. The Memorial Hospital experience. Cancer 61:2325, 1988
84. Pedersen C, Gerstoft J, Lundgren JD, Skinhoj P, Bottzauw J, Geisler C, Hamilton-Dutoit SJ, Thorsen S, Lisse I, Ralfkiaer E: HIV-associated lymphoma: Histopathology and association with Epstein-Barr virus genome related to clinical, immunological and prognostic features. Eur J Cancer 27:1416, 1991
85. Shibata D, Weiss LM, Hernandez AM, Nathwani BN, Bernstein L, Levine AM: Epstein-Barr virus-associated non-Hodgkin's lymphoma in patients infected with the human immunodeficiency virus. Blood 81:2102, 1993
86. Shiramizu B, Herndier B, Meeker T, Kaplan L, McGrath M: Molecular and immunophenotypic characterization of AIDS-associated, Epstein-Barr virus-negative, polyclonal lymphoma [see comments]. J Clin Oncol 10:383, 1992
87. Carbone A, Tirelli U, Gloghini A, Volpe R, Boiocchi M: Human immunodeficiency virus-associated systemic lymphomas may be subdivided into two main groups according to Epstein-Barr viral latent gene expression. J Clin Oncol 11:1674, 1993
88. Camilleri-Broet S, Davi F, Feuillard J, Bourgeois C, Seilhean D, Hauw JJ, Raphael M: High expression of latent membrane protein 1 of Epstein-Barr virus and BCL-2 oncoprotein in acquired immunodeficiency syndrome-related primary brain lymphomas. Blood 86:432, 1995
89. Ballerini P, Gaidano G, Gong JZ, Tassi V, Saglio G, Knowles DM, Dalla-Favera R: Multiple genetic lesions in acquired immunodeficiency syndrome-related non-Hodgkin's lymphoma. Blood 81:166, 1993
90. Gaidano G, Lo Coco F, Ye BH, Shibata D, Levine AM, Knowles DM, Dalla-Favera R: Rearrangements of the BCL-6 gene in acquired immunodeficiency syndrome-associated non-Hodgkin's lymphoma: Association with diffuse large-cell subtype. Blood 84:397, 1994
91. Boyle MJ, Goldstein DA, Frazer IH, Sculley TB: Managing HIV. Part 3: Mechanisms of disease. 3.6. How HIV promotes malignancies. Med J Aust 164:230, 1996
92. Fauci AS, Schnittman SM, Poli G, Koenig S, Pantaleo G: Immunopathogenic mechanisms in human immunodeficiency virus (HIV) infection. Ann Int Med 114:678, 1991
93. Riboldi P, Gaidano G, Schettino EW, Steger TG, Knowles DM, Dalla-Favera R, Casali P: Two acquired immunodeficiency syndrome-associated Burkitt's lymphomas produce specific anti-i IgM cold agglutinins using somatically mutated VH4-21 segments. Blood 83: 2952, 1994
94. Chirmule N, Kalyanaraman VS, Lederman S, Oyaizu N, Yagura H, Yellin MJ, Chess L, Pahwa S: HIV-gp 160-induced T cell-dependent B cell differentiation. Role of T cell-B cell activation molecule and IL-6. J Immunol 150:2478, 1993
95. Ghanekar S, Zheng L, Logar A, Navratil J, Borowski L, Gupta P, Rinaldo C: Cytokine expression by human peripheral blood dendritic cells stimulated in vitro with HIV-1 and herpes simplex virus. J Immunol 157:4028, 1996
96. Ludewig B, Gelderblom HR, Becker Y, Schäfer A, Pauli G: Transmission of HIV-1 from productively infected mature Langerhans cells to primary CD4+ T lymphocytes results in altered T cell responses with enhanced production of IFN-gamma and IL-10. Virology 215:51, 1996
97. Clouse KA, Cosentino LM, Weih KA, Pyle SW, Robbins PB, Hochstein HD, Natarajan V, Farrar WL: The HIV-1 gp120 envelope protein has the intrinsic capacity to stimulate monokine secretion. J Immunol 147:2892, 1991
98. Trentin L, Garbisa S, Zambello R, Agostini C, Caenazzo C, Di Francesco C, Cipriani A, Francavilla E, Semenzato G: Spontaneous production of interleukin-6 by alveolar macrophages from human immunodeficiency virus type 1-infected patients. J Infect Dis 166:731, 1992
99. Gan HX, Ruef C, Hall BF, Tobin E, Remold HG, Mellors JW: Interleukin-6 expression in primary macrophages infected with human immunodeficiency virus-1 (HIV-1). AIDS Res Hum Retroviruses 7:671, 1991
100. Pluda JM, Venzon DJ, Tosato G, Lietzau J, Wyvill K, Nelson DL, Jaffe ES, Karp JE, Broder S, Yarchoan R: Parameters affecting the development of non-Hodgkin's lymphoma in patients with severe human immunodeficiency virus infection receiving antiretroviral therapy. J Clin Oncol 11:1099, 1993
101. Emilie D, Coumbaras J, Raphael M, Devergne O, Delecluse HJ, Gisselbrecht C, Michiels JF, Van Damme J, Taga T, Kishimoto T: Interleukin-6 production in high-grade B lymphomas: Correlation with the presence of malignant immunoblasts in acquired immunodeficiency syndrome and in human immunodeficiency virus-seronegative patients. Blood 80:498, 1992
102. Emilie D, Touitou R, Raphael M, Peuchmaur M, Devergnee O, Rea D, Coumbraras J, Crevon MC, Edelman L, Joab I: In vivo production of interleukin-10 by malignant cells in AIDS lymphomas. Eur J Immunol 22:2937, 1992
103. Benjamin D, Knobloch TJ, Dayton MA: Human B-cell interleukin-10: B-cell lines derived from patients with acquired immunodeficiency syndrome and Burkitt's lymphoma constitutively secrete large quantities of interleukin-10. Blood 80:1289, 1992
104. Levine AM, Sullivan-Halley J, Pike MC, Rarick MU, Loureiro C, Bernstein-Singer M, Willson E, Brynes R, Parker J, Rasheed S: Human immunodeficiency virus-related lymphoma. Prognostic factors predictive of survival [see comments]. Cancer 68:2466, 1991
105. Kaplan LD: The lymphoma project report. Current issues in research and treatment of AIDS-associated lymphoma. Pamphlet published by The Treatment Action Group, New York, NY, 1995
106. Ramsay AD, Smith WJ, Isaacson PG: T-cell-rich B-cell lymphoma. Am J Surg Pathol 12:433, 1988
107. Kieff E, Liebowitz D: Oncogenesis by herpesviruses, in Weinberg RA (ed): Oncogenes and the Molecular Origins of Cancer. Cold Spring Harbor, NY, Cold Spring Harbor Laboratory, 1989, p 259
108. Rowe M, Young LS, Crocker J, Stokes H, Henderson S, Rickinson AB: Epstein-Barr virus (EBV)-associated lymphoproliferative disease in the SCID mouse model: Implications for the pathogenesis of EBV-positive lymphomas in man. J Exp Med 173:147, 1991
109. Hamilton-Dutoit SJ, Raphael M, Audouin J, Diebold J, Lisse I, Pedersen C, Oksenhendler E, Marelle L, Pallesen G: In situ demonstration of Epstein-Barr virus small RNAs (EBER 1) in acquired immunodeficiency syndrome-related lymphomas: correlation with tumor morphology and primary site. Blood 82:619, 1993
110. Chang Y, Cesarman E, Pessin MS, Lee F, Culpepper J, Knowles DM, Moore PS: Identification of herpesvirus-like DNA sequences in AIDS- associated Kaposi's sarcoma. Science 266:1865, 1994
111. Moore PS, Chang Y: Detection of herpesvirus-like DNA sequences in Kaposi's sarcoma in patients with and without HIV infection [see comments]. N Engl J Med 332:1181, 1995
112. Whitby D, Howard MR, Tenant-Flowers M, Brink NS, Copas A, Boshoff C, Hatzioannou T, Suggett FE, Aldam DM, Denton AS: Detection of Kaposi sarcoma associated herpesvirus in peripheral blood of HIV-infected individuals and progression to Kaposi's sarcoma [see comments]. Lancet 346:799, 1995
113. Lipkin M, Higgins P: Biological markers of cell proliferation and differentiation in human gastrointestinal diseases. Adv Cancer Res 50:1, 1988
114. Gaidano G, Pasture C, Gloghini A, Cusini M, Nomdedeu J, Volpe G, Capello D, Vaccher E, Bordes R, Tirelli U, Saglio G, Carbone A: Distribution of human herpesvirus-8 sequences throughout the spectrum of AIDS-related neoplasia. AIDS 10:941, 1996
115. Cesarman E, Nador RG, Bai F, Bohenzky RA, Russo JJ, Moore PS, Chang Y, Knowles DM: Kaposi's sarcoma-associated herpesvirus contains G protein-coupled receptor and cyclin D homologs which are expressed in Kaposi's sarcoma and malignant lymphoma. J Virol 70:8218, 1996
116. Moore PS, Boshoff C, Weiss RA, Chang Y: Molecular mimicry of human cytokine and cytokine response pathway genes by KSHV. Science 274:1739, 1996
117. Rettig MB, Ma HJ, Vescio RA, Pold M, Schiller G, Belson D, Savage A, Nishikubo C, Wu C, Fraser J, Said JW, Berenson JR: Kaposi's sarcoma-associated herpesvirus infection of bone marrow dendritic cells from multiple myeloma patients [see comments]. Science 276:1851, 1997
118. Tang J, Scott G, Ryan DH: Subpopulations of bone marrow fibroblasts support VLA-4-mediated migration of B-cell precursors. Blood 82:3415, 1993
119. Jacobsen K, Osmond DG: Microenvironmental organization and stromal cell associations of B lymphocyte precursor cells in mouse bone marrow. Eur J Immunol 20:2395, 1990
120. Wolf ML, Buckley JA, Goldfarb A, Law CL, LeBien TW: Development of a bone marrow culture for maintenance and growth of normal human B cell precursors. J Immunol 147:3324, 1991
121. Simmons PJ, Masinovsky B, Longenecker BM, Berenson R, Torok-Storb B, Gallatin WM: Vascular cell adhesion molecule-1 expressed by bone marrow stromal cells mediates the binding of hematopoietic progenitor cells. Blood 80:388, 1992
122. McGinnes K, Quesniaux V, Hitzler J, Paige C: Human B-lymphopoiesis is supported by bone marrow-derived stromal cells. Exp Hematol 19:294, 1991
123. Witte PL, Frantsve LM, Hergott M, Rahbe SM: Cytokine production and heterogeneity of primary stromal cells that support B lymphopoiesis. Eur J Immunol 23:1809, 1993
124. Whitlock CA, Witte ON: Long-term culture of murine bone marrow precursors of B lymphocytes. Methods Enzymol 150:275, 1987
125. Whitlock CA, Witte ON: Long-term culture of B lymphocytes and their precursors from murine bone marrow. Proc Natl Acad Sci USA 79:3608, 1982
126. Dexter TM: Haemopoiesis in long-term bone marrow cultures. A review. Acta Haematol 62:299, 1979
127. Dexter TM, Allen TD, Lajtha LG: Conditions controlling the proliferation of haemopoietic stem cells in vitro. J Cell Physiol 91:335, 1977
128. Manabe A, Murti KG, Coustan-Smith E, Kumagai M, Behm FG, Raimondi SC, Campana D: Adhesion-dependent survival of normal and leukemic human B lymphoblasts on bone marrow stromal cells. Blood 83:758, 1994
129. Panayiotidis P, Jones D, Ganeshaguru K, Foroni L, Hoffbrand AV: Human bone marrow stromal cells prevent apoptosis and support the survival of chronic lymphocytic leukaemia cells in vitro. Br J Haematol 92:97, 1996
130. Miyake K, Weissman IL, Greenberger JS, Kincade PW: Evidence for a role of the integrin VLA-4 in lympho-hemopoiesis. J Exp Med 173:599, 1991
131. Juneja HS, Schmalsteig FC, Lee S, Chen J: Vascular cell adhesion molecule-1 and VLA-4 are obligatory adhesion proteins in the heterotypic adherence between human leukemia/lymphoma cells and marrow stromal cells. Exp Hematol 21:444, 1993
132. Koopman G, Keehnen RM, Lindhout E, Newman W, Shimizu Y, van Seventer GA, de Groot C, Pals ST: Adhesion through the LFA-1 (CD11a/CD18)-ICAM-1 (CD54) and the VLA-4 (CD49d)-VCAM-1 (CD106) pathways prevents apoptosis of germinal center B cells. J Immunol 152:3760, 1994
133. Jarvis LJ, LeBien TW: Stimulation of human bone marrow stromal cell tyrosine kinases and IL-6 production by contact with B lymphocytes. J Immunol 155:2359, 1995
134. Dittel BN, McCarthy JB, Wayner EA, LeBien TW: Regulation of human B-cell precursor adhesion to bone marrow stromal cells by cytokines that exert opposing effects on the expression of vascular cell adhesion molecule-1 (VCAM-1). Blood 81:2272, 1993
135. Moses AV, Williams SE, Strussenberg JG, Ostroski ML, Bagby GC, Nelson J: HIV-1 induction of CD40 on endothelial cells promotes the outgrowth of AIDS-associated B cell lymphomas. Nature Med 3: 1242, 1997
136. Bagasra O, Lavi E, Bobroski L, Khalili K, Pestaner JP, Tawadros R, Pomerantz RJ: Cellular reservoirs of HIV-1 in the central nervous system of infected individuals: Identification by the combination of in situ polymerase chain reaction and immunohistochemistry. AIDS 10:573, 1996
137. Ryan DH, Nuccie BL, Abboud CN, Winslow JM: Vascular cell adhesion molecule-1 and the integrin VLA-4 mediate adhesion of human B cell precursors to cultured bone marrow adherent cells. J Clin Invest 88:995, 1991
138. Freedman AS: Expression and function of adhesion receptors on normal B cells and B cell non-Hodgkin's lymphomas. Semin Hematol 30:318, 1993
139. Moses AV, Nelson JA: HIV infection of human brain capillary endothelial cells - Implications for AIDS dementia. Adv Neuroimmunol 4:239, 1994
140. Hollenbaugh D, Mischel-Petty N, Edwards CP, Simon JC, Denfeld RW, Kiener PA, Aruffo A: Expression of functional CD40 by vascular endothelial cells. J Exp Med 182:33, 1995
141. Karmann K, Hughes CC, Schechner J, Fanslow WC, Pober JS: CD40 on human endothelial cells: Inducibility by cytokines and functional regulation of adhesion molecule expression. Proc Natl Acad Sci USA 92:4342, 1995
142. Yellin MJ, Brett J, Baum D, Matsushima A, Szabolcs M, Stern D, Chess L: Functional interactions of T cells with endothelial cells: The role of CD40L-CD40-mediated signals. J Exp Med 182:1857, 1995
143. Noelle RJ, Roy M, Shepherd DM, Stamenkovic I, Ledbetter JA, Aruffo A: A 39-kDa protein on activated helper T cells binds CD40 and transduces the signal for cognate activation of B cells. Proc Natl Acad Sci USA 89:6550, 1992
144. Cocks BG, De Waal Malefyt R, Galizzi JP, De Vries JE, Aversa G: IL-13 induces proliferation and differentiation of human B cells activated by the CD40 ligand. Int Immunol 5:657, 1993
145. Mach F, Schonbeck U, Sukhova GK, Bourcier T, Bonnefoy JY, Pober JS, Libby P: Functional CD40 ligand is expressed on human vascular endothelial cells, smooth muscle cells, and macrophages: Implications for CD40-CD40 ligand signaling in atherosclerosis. Proc Natl Acad Sci USA 94:1931, 1997
146. Grammer AC, Bergman MC, Miura Y, Fujita K, Davis LS, Lipsky PE: The CD40 ligand expressed by human B cell costimulates B cell responses. J Immunol 154:4996, 1995
147. Pinchuk LM, Klaus SJ, Magaletti DM, Pinchuk GV, Norsen JP, Clark EA: Functional CD40 ligand expressed by human blood dendritic cells is up-regulated by CD40 ligation. J Immunol 157:4363, 1996
148. van den Oord JJ, Maes A, Stas M, Nuyts J, Battocchio S, Kasran A, Garmyn M, De Wever I, De Wolf-Peeters C: CD40 is a prognostic marker in primary cutaneous malignant melanoma. Am J Pathol 149:1953, 1996
149. Larson AW, LeBien TW: Cross-linking CD40 on human B cell precursors inhibits or enhances growth depending on the stage of development and the IL costimulus. J Immunol 153:584, 1994
150. Stanley SK, Kessler SW, Justement JS, Schnittman SM, Greenhouse JJ, Brown CC, Musongela L, Musey K, Kapita B, Fauci AS: CD34+ bone marrow cells are infected with HIV in a subset of seropositive individuals. J Immunol 149:689, 1992
151. Kearns K, Bahner I, Bauer G, Wei S, Valdez P, Wheeler S, Woods L, Miller R, Casciato D, Galpin J, Church J, Kohn DB: Suitability of bone marrow from HIV-1-infected donors for retrovirus-mediated gene transfer. Human Gene Ther 8:301, 1997
152. Blazevic V, Heino M, Lagerstedt A, Ranki A, Krohn KJ: Interleukin-10 gene expression induced by HIV-1 Tat and Rev in the cells of HIV-1 infected individuals. J Acquir Immune Defic Syndr Hum Retrovirol 13:208, 1996
153. Takeshita S, Breen EC, Ivashchenko M, Nishanian PG, Kishimoto T, Vredevoe DL, Martinez-Maza O: Induction of IL-6 and IL-10 production by recombinant HIV-1 envelope glycoprotein 41 (gp41) in the THP-1 human monocytic cell line. Cell Immunol 165:234, 1995
154. De Waal Malefyt R, Abrams J, Bennett B, Figdor CG, De Vries JE: Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med 174:1209, 1991
155. Wang P, Wu P, Siegel MI, Egan RW, Billah MM: IL-10 inhibits transcription
156. Cox RA, Anders GT, Cappelli PJ, Johnson JE, Blanton HM, Seaworth BJ, Treasure RL: Production of tumor necrosis factor-alpha and interleukin-1 by alveolar macrophages from HIV-1-infected persons. AIDS Res Hum Retroviruses 6:431, 1990
157. Navikas V, Link J, Wahren B, Persson C, Link H: Increased levels of interferon-gamma (IFN-gamma), IL-4 and transforming growth factor-beta (TGF-beta) mRNA expressing blood mononuclear cells in human HIV infection. Clin Exp Immunol 96:59, 1994
158. Rossol-Voth R, Klein SA, Geissler G, Gute P, Helm EB, Falke D, Hoelzer D: TNF-alpha produced by gamma delta-T-cells as the pivotal pathogenic factor in HIV-infection for the depletion of CD4-pos. T-cells and the inhibition of the hematopoiesis. Int Conf AIDS 8:A69, 1992
159. Husain SR, Leland P, Aggarwal BB, Puri RK: Transcriptional up-regulation of interleukin 4 receptors by human immunodeficiency virus type 1 tat gene. AIDS Res Hum Retroviruses 12:1349, 1996
160. Brady HJ, Abraham DJ, Pennington DJ, Miles CG, Jenkins S, Dzierzak EA: Altered cytokine expression in T lymphocytes from human immunodeficiency virus Tat transgenic mice. J Virol 69:7622, 1995
161. Gallicchio VS, Tse KF, Morrow J, Hughes NK: Suppression of hematopoietic support function is associated with overexpression of interleukin-4 and transforming growth factor-b1 in LP-BM5 murine-leukemia-virus-infected stromal cell lines. Acta Haematol 95:204, 1996
162. Gautam SC, Noth CJ, Janakiraman N, Pindolia KR, Chapman RA: Induction of chemokine mRNA in bone marrow stromal cells: Modulation by TGF-beta 1 and IL-4. Exp Hematol 23:482, 1995
163. Sunila I, Vaccarezza M, Pantaleo G, Fauci AS, Orenstein JM: Gp120 is present on the plasma membrane of apoptotic CD4 cells prepared from lymph nodes of HIV-1-infected individuals: An immunoelectron microscopic study. AIDS 11:27, 1997
164. Kolesnitchenko V, Wahl LM, Tian H, Sunila I, Tani Y, Hartmann DP, Cossman J, Raffeld M, Orenstein J, Samelson LE: Human immunodeficiency virus 1 envelope-initiated G2-phase programmed cell death. Proc Natl Acad Sci USA 92:11889, 1995
165. Takenaka K, Nagafuji K, Harada M, Miyamoto T, Makino S, Gondo H, Okamura T, Niho Y: In vitro expansion of hematopoietic progenitor cells induces functional expression of fas antigen (CD95). Blood 88:2871, 1996
166. Barcena A, Park SW, Banapour B, Muench MO, Mechetner E: Expression of Fas/CD95 and Bcl-2 by primitive hematopoietic progenitors freshly isolated from human fetal liver. Blood 88:2013, 1996
167. Maciejewski JP, Weichold FF, Young NS: HIV-1 suppression of hematopoiesis in vitro mediated by envelope glycoprotein and TNF- alpha. J Immunol 153:4303, 1994
168. Roux-Lombard P, Modoux C, Cruchaud A, Dayer J-M: Purified blood monocytes from HIV 1-infected patients produce high levels of TNFa and IL-1. Clin Immunol Immunopathol 50:374, 1989
169. Zauli G, Davis BR, Re MC, Visani G, Furlini G, La Placa M: tat Protein stimulates production of transforming growth factor-b1 by marrow macrophages: A potential mechanism for human immunodeficiency virus-1-induced hematopoietic suppression. Blood 80:3036, 1992
170. Lotz M, Seth P: TGF beta and HIV infection. Ann NY Acad Sci 685:501, 1993
171. + alveolitis. Clin Exp Immunol 96:187, 1994
172. Zauli G, Vitale M, Gibellini D, Capitani S: Inhibition of purified CD34+ hematopoietic progenitor cells by human immunodeficiency virus 1 or gp120 mediated by endogenous transforming growth factor beta 1. J Exp Med 183:99, 1996
173. Folks TM, Kessler SW, Orenstein JM, Justement JS, Jaffe ES, Fauci AS: Infection and replication of HIV-1 in purified progenitor cells of normal human bone marrow. Science 242:919, 1988
174. Steinberg HN, Crumpacker CS, Chatis PA: In vitro suppression of normal human bone marrow progenitor cells by human immunodeficiency virus. J Virol 65:1765, 1991
175. Kojouharoff G, Ottmann OG, Von Briesen H, Geissler G, Rubsamen-Waigmann H, Hoelzer D, Ganser A: Infection of granulocyte/monocyte progenitor cells with HIV1. Res Virol 142:151, 1991
176. Zauli G, Re MC, Giovannini M, Bagnara GP, Furlini G, Ranieri S, La Placa M: Effect of human immunodeficiency virus type 1 on CD34+ cells. Ann NY Acad Sci 628:273, 1991
177. +) hematopoietic progenitor cells. Arch Virol 122:271, 1992
178. Calenda V, Sebahoun G, Chermann JC: Modulation of normal human erythropoietic progenitor cells in long-term liquid cultures after HIV-1 infection. AIDS Res Hum Retroviruses 8:61, 1992
179. Cen D, Zauli G, Szarnicki R, Davis BR: Effect of different human immunodeficiency virus type-1 (HIV-1) isolates on long-term bone marrow haemopoiesis Effect of different human immunodeficiency virus type-1 (HFV-1) isolates on long-term bone marrow haemopoiesis. Br J Haematol 85:596, 1993
180. Schwartz GN, Kessler SW, Szabo JM, Burrell LM, Francis ML: Negative regulators may mediate some of the inhibitory effects of HIV-1 infected stromal cell layers on erythropoiesis and myelopoiesis in human bone marrow long term cultures. J Leukoc Biol 57:948, 1995
181. Kaushal S, La Russa VF, Gartner S, Kessler S, Perfetto S, Yu Z, Ritchey DW, Xu J, Perera P, Kim J, Reid T, Mayers DL, St. Louis D, Mosca JD: Exposure of human CD34+ cells to human immunodeficiency virus type 1 does not influence their expansion and proliferation of hematopoietic progenitors in vitro. Blood 88:130, 1996
182. Donahue RE, Johnson MM, Zon LI, Clark SC, Groopman JE: Suppression of in vitro haematopoiesis following human immunodeficiency virus infection. Nature 326:200, 1987
183. Von Laer D, Hufert FT, Fenner TE, Schwander S, Dietrich M, Schmitz H, Kern P: CD34+ hematopoietic progenitor cells are not a major reservoir of the human immunodeficiency virus. Blood 76:1281, 1990
184. Ganser A, Ottmann OG, Von Briesen H, Volkers B, Rubsamen-Waigmann H, Hoelzer D: Changes in the haematopoietic progenitor cell compartment in the acquired immunodeficiency syndrome. Res Virol 141:185, 1990
185. Zauli G, Re MC, Davis B, Sen L, Visani G, Gugliotta L, Furlini G, La Placa M: Impaired in vitro growth of purified (CD34+) hematopoietic progenitors in human immunodeficiency virus-1 seropositive thrombocytopenic individuals. Blood 79:2680, 1992
186. Louache F, Henri A, Bettaieb A, Oksenhendler E, Raguin G, Tulliez M, Vainchenker W: Role of human immunodeficiency virus replication in defective in vitro growth of hematopoietic progenitors. Blood 80:2991, 1992
187. Kaczmarski RS, Davison F, Blair E, Sutherland S, Moxham J, McManus T, Mufti GJ: Detection of HIV in haemopoietic progenitors. Br J Haematol 82:764, 1992
188. Dallalio G, North M, Means RT Jr: Inhibition of marrow CFU-E colony formation from human immunodeficiency virus-infected patients by b- and gamma-interferon. Am J Hematol 53:118, 1996
189. Marandin A, Katz A, Oksenhendler E, Tulliez M, Picard F, Vainchenker W, Louache F: Loss of primitive hematopoietic progenitors in patients with human immunodeficiency virus infection. Blood 88:4568, 1996